COVID-19 Antibodies
Lilly is co-developing two monoclonal antibody products with partners. Lilly estimates it could have an emergency use authorization for one of the products as soon this fall.
Comments are closed.
|
Stay informed, subscribe to the Prescribe Right Pharmaceutical Pipeline Tracker
Archives
January 2023
Categories |
Services |
Company |
|
© COPYRIGHT 2015. ALL RIGHTS RESERVED.
|